{
  "metadata": {
    "doi": "10.1038/nrd842",
    "title": "Selective anticancer drugs",
    "pmid": "12120255",
    "DOI": "10.1038/nrd842",
    "type": "journal-article",
    "issn": [
      "1474-1776",
      "1474-1784"
    ],
    "journal": "Nature Reviews Drug Discovery",
    "shortname": "Nature Reviews Drug Discovery",
    "journal_short": "Nature Reviews Drug Discovery",
    "publisher": "Springer Science and Business Media LLC",
    "published": "2002-07-01",
    "issue": "7",
    "volume": "1",
    "pages": "491-492",
    "year": "2002",
    "author": [
      {
        "given": "Joshua H.",
        "family": "Atkins",
        "name": "Joshua H. Atkins",
        "affiliation": [
          {
            "name": "AGW BioStrategy, 55 West 26 Street, Suite 10D, New York, New York 10010, USA."
          }
        ]
      },
      {
        "given": "Leland",
        "family": "Gershell",
        "name": "Leland Gershell"
      }
    ],
    "keyword": [
      "Breast Cancer",
      "Therapeutic Resistance",
      "Molecular Response",
      "Tyrosine Kinase Inhibitors",
      "Drug approval"
    ]
  }
}